FRONTotemporal dementia Incidence European Research Study-FRONTIERS: Rationale and design.

epidemiology frontotemporal dementia frontotemporal lobar degeneration incidence rare diseases registry

Journal

Alzheimer's & dementia : the journal of the Alzheimer's Association
ISSN: 1552-5279
Titre abrégé: Alzheimers Dement
Pays: United States
ID NLM: 101231978

Informations de publication

Date de publication:
03 2022
Historique:
revised: 22 05 2021
received: 01 02 2021
accepted: 09 06 2021
pubmed: 3 8 2021
medline: 26 4 2022
entrez: 2 8 2021
Statut: ppublish

Résumé

The incidence of Frontotemporal Lobar Degeneration (FTLD)-related disorders and their characteristics are not well known. The "FRONTotemporal dementia Incidence European Research Study" (FRONTIERS) is designed to fill this gap. FRONTIERS is a European prospective, observational population study based on multinational registries. FRONTIERS comprises 11 tertiary referral centers across Europe with long-lasting experience in FTLD-related disorders and comprehensive regional referral networks, enabling incidence estimation over well-defined geographical areas. The primary endpoints are (1) the incidence of FTLD-related disorders across Europe; (2) geographic trends of FTLD-related disorders; (3) the distribution of FTLD phenotypes in different populations and ethnicities in Europe; (4) inheritance of FTLD-related disorders, including the frequencies of monogenic FTLD as compared to overall disease burden; and (5) implementation of data banking for clinical and biological material. FRONTIERS will improve the understanding of FTLD-related disorders and their epidemiology, promoting appropriate public health service policies and treatment strategies.

Identifiants

pubmed: 34338439
doi: 10.1002/alz.12414
pmc: PMC9291221
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

498-506

Subventions

Organisme : Medical Research Council
ID : MR/M009041/1
Pays : United Kingdom
Organisme : Department of Health
ID : BRC-1215-20014
Pays : United Kingdom
Organisme : Medical Research Council
ID : G101400
Pays : United Kingdom
Organisme : Wellcome Trust
Pays : United Kingdom

Informations de copyright

© 2021 The Authors. Alzheimer's & Dementia published by Wiley Periodicals LLC on behalf of Alzheimer's Association.

Références

J Neurol Neurosurg Psychiatry. 2017 Jul;88(7):557-563
pubmed: 28285264
Neuroepidemiology. 2019;52(1-2):93-103
pubmed: 30602169
Acta Neuropathol. 2015 Apr;129(4):469-91
pubmed: 25549971
Ann Neurol. 2013 Nov;74(5):699-708
pubmed: 23836460
Curr Opin Neurobiol. 2020 Apr;61:29-39
pubmed: 31838254
Parkinsonism Relat Disord. 2020 Oct;79:121-126
pubmed: 32947108
Neurology. 2011 Mar 15;76(11):1006-14
pubmed: 21325651
Int Rev Psychiatry. 2013 Apr;25(2):130-7
pubmed: 23611343
Neurology. 2017 Jun 13;88(24):2321-2329
pubmed: 28515268
Acta Neuropathol. 2010 Jan;119(1):1-4
pubmed: 19924424
Neurology. 2016 May 3;86(18):1736-43
pubmed: 27037234
Lancet Neurol. 2020 Feb;19(2):145-156
pubmed: 31810826
Neurology. 2004 Feb 10;62(3):506-8
pubmed: 14872045
Brain. 2003 Sep;126(Pt 9):2016-22
pubmed: 12876142
Mov Disord. 2017 Jun;32(6):853-864
pubmed: 28467028
Alzheimers Dement. 2020 Jan;16(1):106-117
pubmed: 31914218
Brain. 2007 Jun;130(Pt 6):1552-65
pubmed: 17405767
J Neurol Neurosurg Psychiatry. 2019 Feb;90(2):157-164
pubmed: 30309882
Neuroepidemiology. 2020;54(2):114-122
pubmed: 31910416
Brain. 2020 May 1;143(5):1555-1571
pubmed: 32438414
Brain. 2011 Sep;134(Pt 9):2456-77
pubmed: 21810890
Int J Epidemiol. 2018 Aug 1;47(4):1343-1354
pubmed: 29939274
Acta Neuropathol. 2014 Sep;128(3):423-37
pubmed: 24916269
Alzheimer Dis Assoc Disord. 2011 Oct-Dec;25(4):341-4
pubmed: 21399481
Neurology. 2019 May 14;92(20):e2355-e2363
pubmed: 30979859
Biochim Biophys Acta. 2006 Nov-Dec;1762(11-12):1150-7
pubmed: 17071060
Brain. 2005 Sep;128(Pt 9):1996-2005
pubmed: 16033782
Neurology. 2013 Jan 29;80(5):496-503
pubmed: 23359374
Epidemiol Rev. 1995;17(2):243-64
pubmed: 8654510
Brain. 2011 Sep;134(Pt 9):2565-81
pubmed: 21908872
J Neurol Neurosurg Psychiatry. 2003 Sep;74(9):1206-9
pubmed: 12933919
J Neurol Neurosurg Psychiatry. 2020 Feb;91(2):125
pubmed: 31672700
Front Aging Neurosci. 2015 Sep 01;7:171
pubmed: 26388768
Alzheimers Dement. 2021 Jan;17(1):81-88
pubmed: 32914938
J Neurol Neurosurg Psychiatry. 2008 Jan;79(1):6-11
pubmed: 18079297
Alzheimers Dement. 2022 Mar;18(3):498-506
pubmed: 34338439
Acta Neuropathol. 2014 Mar;127(3):391-6
pubmed: 24496499
J Clin Epidemiol. 2000 Oct;53(10):1025-9
pubmed: 11027935
Brain. 2017 Dec 1;140(12):3329-3345
pubmed: 29053860
Alzheimers Dement. 2020 Mar;16(3):482-490
pubmed: 31784373
J Neurol Neurosurg Psychiatry. 2003 Jul;74(7):867-71
pubmed: 12810769

Auteurs

Barbara Borroni (B)

Centre for Neurodegenerative Disorders, Neurology Unit, ASST Spedali Civili Brescia and University of Brescia, Brescia, Italy.

Caroline Graff (C)

Department NVS, Division of Neurogeriatrics, Karolinska Institutet, Stockholm, Sweden.
Unit for Hereditary Dementia, Theme Aging, Karolinska University Hospital-Solna, Stockholm, Sweden.

Orla Hardiman (O)

Academic Unit of Neurology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland.
Department of Neurology, Beaumont Hospital, Dublin, Ireland.

Albert C Ludolph (AC)

Department of Neurology, University Hospital Ulm, Ulm, Germany.
Deutsches Zentrum für neurodegenerative Erkrankungen (DZNE), Ulm, Germany.

Fermin Moreno (F)

Department of Neurology, Cognitive Disorders Unit, Hospital Universitario Donostia, San Sebastian, Spain.
Neuroscience Area, Biodonostia Health Research Institute, San Sebastian, Spain.

Markus Otto (M)

Department of Neurology, University Hospital Ulm, Ulm, Germany.

Marco Piccininni (M)

Institute of Public Health, Charité, Universitätsmedizin Berlin, Berlin, Germany.

Anne M Remes (AM)

Unit of Clinical Neuroscience, Neurology, University of Oulu, Oulu, Finland.
Medical Research Center, Oulu University Hospital, Oulu, Finland.

James B Rowe (JB)

Department of Clinical Neurosciences, MRC Cognition and Brain Sciences Unit, and Cambridge University Hospitals NHS Trust, University of Cambridge, Cambridge, UK.

Harro Seelaar (H)

Department of Neurology and Alzheimer center, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands.

Elka Stefanova (E)

Faculty of Medicine, Neurology Clinic, University of Belgrade, University Clinical Center Serbia, Serbia.

Latchezar Traykov (L)

Department of Neurology, UH "Alexandrovska", Medical University Sofia, Sofia, Bulgaria.

Giancarlo Logroscino (G)

Center for Neurodegenerative Diseases and the Aging Brain, Pia Fondazione di Culto e Religione, Cardinale Giovanni Panico, University of Bari-Aldo Moro, Bari, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH